Literature DB >> 15014180

Paul Ehrlich's magic bullets.

Robert S Schwartz.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15014180     DOI： 10.1056/NEJMp048021

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  43 in total

1.  Cancer pharmacotherapy: 21st century 'magic bullets' and changing paradigms.

Authors:  L D Lewis
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

2.  Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

Authors:  Xing Du; Richard Beers; David J Fitzgerald; Ira Pastan
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 3.  Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.

Authors:  William D Hedrich; Tamer E Fandy; Hossam M Ashour; Hongbing Wang; Hazem E Hassan
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

4.  Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase.

Authors:  Dimitris Platis; Brian J Smith; Trevor Huyton; Nikolaos E Labrou
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

5.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

6.  Thermosensitive Biodegradable Copper Sulfide Nanoparticles for Real-Time Multispectral Optoacoustic Tomography.

Authors:  Sixiang Shi; Xiaofei Wen; Tingting Li; Xiaoxia Wen; Qizhen Cao; Xinli Liu; Yiyao Liu; Mark D Pagel; Chun Li
Journal:  ACS Appl Bio Mater       Date:  2019-07-04

Review 7.  The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

Authors:  Fèlix Bosch; Laia Rosich
Journal:  Pharmacology       Date:  2008-08-05       Impact factor: 2.547

Review 8.  Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.

Authors:  Aiko Nagayama; Leif W Ellisen; Bruce Chabner; Aditya Bardia
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

Review 9.  Melanoma vaccines: mixed past, promising future.

Authors:  Junko Ozao-Choy; Delphine J Lee; Mark B Faries
Journal:  Surg Clin North Am       Date:  2014-08-07       Impact factor: 2.741

Review 10.  [Immunmodulatory antibodies in the treatment of skin cancer].

Authors:  D Schrama; A Hauschild; J C Becker
Journal:  Hautarzt       Date:  2008-10       Impact factor: 0.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.